CD8A and cancer: In such tumors, genetic ablation of cyclooxygenases, encoded by the Ptgs1 and Ptgs2 genes, leads to inability to produce PGE2 and renders the cancers susceptible to cDC1-dependent CD8+ T cell-mediated immune control (Zelenay et al., 2015).